Perkin Elmer (UK) launches in situ amplification system:
This article was originally published in Clinica
Perkin Elmer (UK) has launched GeneAmp, the first complete in situ PCR system. The thermocycler can amplify up to 30 samples in a single run, using a vertical ten-slide block without mineral oils or adhesives. Perkin Elmer says the system has applications in neoplastic disorders, gene rearrangements, chromosome translocations and cell-specific gene expression and claims it will revolutionise molecular medicine, cancer research and applied genetics.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.